Ensign Group Q4 adjusted EPS beats expectations, revenue up 20.2%

Ensign group

04/02/2026 21:20

Overview

Post-acute healthcare provider's Q4 adjusted EPS beat analyst expectations

Q4 revenue increased 20.2% yr/yr

Company added 17 new operations during the quarter

Outlook

Ensign projects 2026 earnings per share between $7.41 and $7.61

Company forecasts 2026 revenue between $5.77 bln and $5.84 bln

Ensign sees organic growth potential from current occupancy rates

Result Drivers

OCCUPANCY INCREASE - Same Facilities and Transitioning Facilities occupancy rates rose to 83.8% and 84.9% respectively, reaching all-time highs

MEDICARE REVENUE GROWTH - Medicare revenue for Same Facilities and Transitioning Facilities improved by 15.7% and 11.3% respectively over the prior year quarter

NEW ACQUISITIONS - Company added 17 new operations, including 12 real estate assets, contributing to growth

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Rental Revenue
$6.74 mln
Q4 Adjusted EPS
Beat
$6.57
$1.77 (4 Analysts)
Q4 EPS
$5.84
Q4 Net Income
$95.53 mln
Q4 Operating Income
$123.81 mln
Q4 Service Revenue
$1.35 bln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the healthcare facilities & services peer group is "buy"

Wall Street's median 12-month price target for Ensign Group Inc is $206.00, about 18.7% above its February 3 closing price of $173.60

The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 26 three months ago

Press Release: ID:nGNX2Ckh1R

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)